Effect of Cognitive Disability and Ambulation Status on Functioning in Moderate-to-Advanced Parkinson Disease

被引:7
|
作者
Wang, Chen Yu [1 ]
Chan, Lung [1 ,2 ]
Wu, Dean [1 ,2 ]
Chi, Wen-chou [3 ,4 ]
Yen, Chia-Feng [3 ,5 ]
Liao, Hua-Fang [3 ,6 ]
Hong, Chien Tai [1 ,2 ]
Liou, Tsan-Hon [3 ,7 ,8 ,9 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Dept Neurol, Sch Med, Taipei, Taiwan
[3] TSICF, Taiwan Soc Int Classificat Functioning Disabil &, New Taipei, Taiwan
[4] Chung Shan Med Univ, Dept Occupat Therapy, Taichung, Taiwan
[5] Tzu Chi Univ, Dept Publ Hlth, Hualien, Taiwan
[6] Natl Taiwan Univ, Coll Med, Sch & Grad Inst Phys Therapy, Taipei, Taiwan
[7] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, New Taipei, Taiwan
[8] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan
[9] Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan
来源
FRONTIERS IN NEUROLOGY | 2020年 / 10卷
关键词
Parkinson's disease; disability; cognition; ambulation; WHODAS; 2; 0; NONMOTOR SYMPTOMS; DEMENTIA; PROGRESSION; DIAGNOSIS; EVOLUTION; CRITERIA; HEALTH; MOTOR;
D O I
10.3389/fneur.2019.01360
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: As the disease progresses to moderate to advanced stages, people with Parkinson's disease (PwP) are likely to have various degrees of disability due to the motor and non-motor symptoms, such as ambulatory difficulty and cognitive impairment. The objective of this study was to investigate the impact of cognition and ambulation status on the functioning and disability of PwP using the World Health Orgnaization Disability Assessment Schedule 2.0 (WHODAS 2.0). Materials and Methods: A group of 10,581 PwP with Hoehn and Yahr Staging 3 and above were collected from a database of disability evaluation and functional assessment using the Taiwan Data Bank of Persons with Disability between July 2012 and October 2018. WHODAS 2.0 was administered and all PwP were grouped based on their ambulatory status, which was assessed by 3-m back and forth walk and cognitive ability, assessed by WHODAS 2.0 first domain with cut-off level at 58. Results: Non-ambulation and cognitive disability contributed independently to disability in all aspects of WHODAS 2.0 survey, including self-care, getting along with others, performing life activities and participation in society. Compared to ambulation status, cognitive disability had a greater negative impact on functioning in all aspects. Conclusion: Cognitive disability was associated with greater disability in moderate to advanced PwP than non-ambulatory status. The results of this study may indicate that cognition preservation is essential to ameliorate functional impairment and disability in moderate to advanced PwP.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Hand Fine Motor Skill Disability Correlates with Cognition in Patients with Moderate-to-Advanced Parkinson's Disease
    Tan, Shennie
    Hong, Chien Tai
    Chen, Jia-Hung
    Chan, Lung
    Chi, Wen-Chou
    Yen, Chia-Feng
    Liao, Hua-Fang
    Liou, Tsan-Hon
    Wu, Dean
    BRAIN SCIENCES, 2020, 10 (06)
  • [2] Unilateral Ablative Lesions of the Subthalamic Nucleus in Moderate-to-Advanced Parkinson's Disease
    Hanagasi, Hasmet A.
    Barlas, Orhan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 (02): : 114 - 118
  • [3] Deterioration of fine motor skills and functional disability in patients with moderate-to-advanced Parkinson disease: A longitudinal follow-up study
    Huang, Yin-Chia
    Hong, Chien-Tai
    Chi, Wen-Chou
    Yen, Chia-Feng
    Liao, Hua- Fang
    Liou, Tsan-Hon
    Chan, Lung
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2024, 121
  • [4] Multidisciplinary intensive outpatient rehabilitation program for patients with moderate-to-advanced Parkinson's disease
    Cohen, Noa
    Manor, Yael
    Green, Yitzhak
    Tahel, Gail
    Badichi, Inbal
    Ben-Or, Galit
    Shtainshlaifer, Neta
    Shiffer, Asaf
    Gabso-Rajuan, Maayan
    Kurtzman, Hadar
    Shtraifler, Liat
    Furst, Tova
    Shtein, Shlomi
    Shulman, Juli
    Hyute, Anat
    Levin, Issachar
    Inbar, Noit
    Ariela, Hilel
    Peled, Roni
    Gheriani, Nurit
    Ezra, Adi
    Messer, Stav
    Geva, Noya
    Giladi, Nir
    Gurevich, Tanya
    NEUROREHABILITATION, 2021, 49 (01) : 47 - 55
  • [5] A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
    Schlackow, Iryna
    Kent, Seamus
    Herrington, William
    Emberson, Jonathan
    Haynes, Richard
    Reith, Christina
    Wanner, Christoph
    Fellstrom, Bengt
    Gray, Alastair
    Landray, Martin J.
    Baigent, Colin
    Mihaylova, Borislava
    HEART, 2017, 103 (23) : 1880 - 1890
  • [6] Rasagiline provides significant management of motor symptoms in early and moderate-to-advanced Parkinson's disease (PD).
    Berchou, RC
    Chen, JJ
    PHARMACOTHERAPY, 2005, 25 (10): : 1467 - 1467
  • [7] Functioning and disability in Parkinson's disease
    Raggi, Alberto
    Leonardi, Matilde
    Ajovalasit, Daniela
    Carella, Francesco
    Soliveri, Paola
    Albanese, Alberto
    Romito, Luigi
    DISABILITY AND REHABILITATION, 2010, 32 : S33 - S41
  • [8] Rasagiline provides significant symptom benefit as initial monotherapy and as adjunct therapy in early and moderate-to-advanced Parkinson's disease
    Salzman, PM
    Eyal, E
    Kunkel, TJ
    Malone, NT
    ANNALS OF NEUROLOGY, 2004, 56 : S13 - S13
  • [9] Integration of the expanded disability status scale with ambulation, visual and cognitive tests
    Sarnataro, Alessio
    Cuomo, Nunzia
    Russo, Cinzia Valeria
    Carotenuto, Antonio
    Lanzillo, Roberta
    Moccia, Marcello
    Petracca, Maria
    Morra, Vincenzo Brescia
    Sacca, Francesco
    NEUROLOGICAL SCIENCES, 2024, 45 (10) : 4799 - 4805
  • [10] Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD)
    Morrison, CE
    Borod, JC
    Brin, MF
    Hälbig, TD
    Olanow, CW
    JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (10-11) : 1333 - 1341